| Grogan, Eric L |
Vanderbilt University Medical Center
United States |
Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer |
2U01CA152662-11 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Grogan, Eric L |
Vanderbilt University Medical Center
United States |
Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer |
2U01CA152662-11 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Haab, Brian B. |
Van Andel Research Institute
United States |
Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers |
5U01CA226158-04 |
PAR-17-206 (U01) |
Sharmistha Ghosh-Janjigian, Ph.D. |
| Haab, Brian B. |
Van Andel Research Institute
United States |
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers |
3U01CA152653-10S1 |
|
Jo Ann Rinaudo, Ph.D. |
| Hanash, Samir M |
University Of Tx Md Anderson Can Ctr
United States |
Clinical Validation Center for Lung Cancer Early Detection |
1U01CA271888-01 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Hanash, Samir M |
University Of Tx Md Anderson Can Ctr
United States |
Clinical Validation Center for Lung Cancer Early Detection |
1U01CA271888-01 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Hecht, Stephen S |
University Of Minnesota
United States |
High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck |
5R01CA263084-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Wendy Wang, Ph.D., M.Sc. |
| Heinrich, Michael C |
Oregon Health & Science University
United States |
Novel models for functional profiling of germline SDH variants associated with cancer |
5R21CA263400-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Richard Mazurchuk, Ph.D. |
| Herman, James G. |
University Of Pittsburgh At Pittsburgh
United States |
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer |
3U01CA214165-05S1 |
|
Wendy Wang, Ph.D., M.Sc. |
| Hirsch, Fred R |
Icahn School Of Medicine At Mount Sinai
United States |
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses |
3U54CA260560-02S1 |
|
Guillermo Marquez, Ph.D. |